Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice.
Author | |
---|---|
Abstract | :
Sleep disruption is a characteristic of Alzheimer's disease (AD) that may exacerbate disease progression. This study tested whether a dual orexin receptor antagonist (DORA) would enhance sleep and attenuate neuropathology, neuroinflammation, and cognitive deficits in an AD-relevant mouse model, 5XFAD. |
Year of Publication | :
0
|
Journal | :
Alzheimer's & dementia (New York, N. Y.)
|
Volume | :
5
|
Number of Pages | :
70-80
|
Date Published | :
2019
|
DOI | :
10.1016/j.trci.2019.01.003
|
Short Title | :
Alzheimers Dement (N Y)
|
Download citation |